Y-Intercept (Hong Kong) Ltd

Position in IQV — Iqvia Holdings Inc.

CIK 1772875 HONG KONG, K3

Position in IQV

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,115,759

+$1,704,588 QoQ

Shares Held

10,950

+354.2% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#23

of 107 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names. IQV ranks #5 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IDXX	Idexx Laboratories Inc /De	16,330	$8,596,765
2	GH	Guardant Health, Inc.	52,547	$7,883,626
3	ILMN	Illumina, Inc.	18,655	$3,280,108
4	ADPT	Adaptive Biotechnologies Corp	135,137	$2,898,688
5	IQV	Iqvia Holdings Inc. This page	10,950	$2,115,759
6	WGS	GeneDx Holdings Corp.	27,521	$1,889,316
7	TMO	Thermo Fisher Scientific Inc.	2,669	$1,338,129
8	LH	Labcorp Holdings Inc.	4,074	$1,140,720

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,115,759	10,950	+354.2%	Shares	Sole	2026-07-14
2026-03-31	$411,171	2,411	+12.0%	Shares	Sole	2026-04-27
2025-12-31	$485,307	2,153	+75.6%	Shares	Sole	2026-02-13
2025-03-31	$216,143	1,226	-81.5%	Shares	Sole	2025-05-06
2024-12-31	$1,305,219	6,642	-55.6%	Shares	Sole	2025-02-04
2024-09-30	$3,542,701	14,950	+1.8%	Shares	Sole	2024-11-15
2024-06-30	$3,103,939	14,680	+399.3%	Shares	Sole	2024-08-14
2023-06-30	$660,823	2,940	-58.9%	Shares	Sole	2023-08-14
2023-03-31	$1,424,052	7,160	-4.6%	Shares	Sole	2023-05-09
2022-12-31	$1,537,494	7,504	-63.2%	Shares	Sole	2023-02-14
2022-09-30	$3,694,169	20,394	+661.5%	Shares	Sole	2023-02-14
2021-12-31	$755,570	2,678	-12.5%	Shares	Sole	2022-02-14
2021-03-31	$591,201	3,061	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.